InvestorsHub Logo

longfellow95

04/21/18 8:02 AM

#168972 RE: Milner1 #168968

Where does it say that the SEC is looking into the manuscript is this documented anywhere?


From Senti's quote from the 10k

As previously reported, the Company has received a number formal information requests (subpoenas) from the SEC regarding several broad topics that have been previously disclosed, including the Company’s membership on Nasdaq and delisting, related party matters, the Company’s programs, internal controls, the Company’s Special Litigation Committee, disclosures and the planned publication of interim clinical trial data. Testimony of certain officers and third parties has been taken as well. The Company is cooperating with the SEC investigation and is hopeful that it is reaching its final stages.



Unless you think the manuscript is different to 'the planned publication of interim clinical trial data.'

I don't.